Inspiration Healthcare announces Roy Davis as Executive Chair and Interim CEO alongside Neil Campbell stepping to Non-Executive Director role

– UK, Crawley –  Inspiration Healthcare Group plc (LON: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces that Neil Campbell will step down as CEO to become a Non-Executive Director. Concurrently, Roy Davis, Non-Executive Chair is to become Executive Chairman and Interim CEO.

About Neil Campbell

Neil Campbell will formally leave full-time employment with the Company at the end of June and become a consultant to the business as a Global Advocate supporting key relationships and business development opportunities. Neil has been with the Group for over 20 years having been one of the founders of Inspiration Healthcare and was appointed as CEO of the Group in June 2015.

Neil Campbell commented: “I am pleased to be able to transition from an executive to a Non-Executive role with Inspiration Healthcare. While the business has experienced some challenges in recent times, I am incredibly proud of what we have achieved from start-up 20 years ago to where it is today. I look forward to being able to continue to contribute to the business as a Non-Executive Director.”

About Roy Davis

Roy Davis brings a wealth of commercial experience in medical device companies and has a proven track record of successfully scaling companies and delivering substantial value for shareholders. His expertise includes delivering sales growth strategies, transforming business operations, enhancing operational efficiency, and increasing productivity to yield higher profits. He has held leadership positions at several publicly quoted med tech companies, including as Non-Executive Chair at Medica Group plc, a leading UK tele-radiology company until its acquisition by IK partners for £269m in 2024. He was also CEO of Optos plc, a leading retinal imaging device manufacturer from 2008 to 2016 until its sale to Nikon for $400 million in 2015, and CEO of Gyrus Group plc, a leader in minimally invasive surgery and visualization, until its acquisition by Olympus Corporation in 2008 for $1.9 billion.

Roy Davis said: “Neil has played an important role over the last 20 years in founding the business, as a dedicated member of the Inspiration team and as Board member. I would like to thank Neil for his tireless commitment to the business and look forward to his continued involvement as a Non-Executive Director and advisor going forward. In becoming Executive Chairman and Interim CEO I look forward to working with the team to help Inspiration Healthcare on the next stage of its journey and to achieving its full potential.”

About Inspiration Healthcare

Inspiration Healthcare designs, manufactures, and markets pioneering medical technology. Based in the UK, the Company specializes in neonatal intensive care medical devices, which address a critical need to help save lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world, the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London, and from its facility in Hailsham, East Sussex, and in the USA from its facility in Melbourne, Florida.


- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.